169 related articles for article (PubMed ID: 38153861)
1. Predictors of flare-related inpatient or emergency department stay in systemic lupus erythematosus: A real-world analysis of Medicaid claims in the United States.
Wu SS; Perry A; Zimmerman NM; Bryant G
J Manag Care Spec Pharm; 2024 Jan; 30(1):61-70. PubMed ID: 38153861
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic characterization of mild, moderate, and severe systemic lupus erythematosus: Real-world observation across payer channels in the United States.
Wu SS; Perry A; Tkacz J; Bryant G
J Manag Care Spec Pharm; 2023 Sep; 29(9):1010-1020. PubMed ID: 37610115
[No Abstract] [Full Text] [Related]
3. Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS).
Dhital R; Pokharel A; Karageorgiou I; Poudel DR; Guma M; Kalunian K
Lupus; 2023 Dec; 32(14):1646-1655. PubMed ID: 37961765
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States.
Bell CF; Ajmera MR; Meyers J
Lupus; 2022 Feb; 31(2):202-211. PubMed ID: 35060407
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus.
Nagai Y; Yokogawa N; Shimada K; Sugii S
Rheumatol Int; 2019 Sep; 39(9):1567-1573. PubMed ID: 31309295
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of patients with initial diagnosis of systemic lupus erythematosus in emergency department and their outcomes: a retrospective single-center study.
Zhang X; Song X; Lv S; Li J; Jin Y; Jin J; Shao M; Zhu J; Chi C
Clin Rheumatol; 2024 Feb; 43(2):667-676. PubMed ID: 38150055
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus.
Lokhandwala T; Coutinho AD; Bell CF
Clin Ther; 2021 Aug; 43(8):1320-1335. PubMed ID: 34243966
[TBL] [Abstract][Full Text] [Related]
8. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
9. Development of a claims-based flare algorithm for systemic lupus erythematosus.
Goetz I; Choong C; Winnie J; Nelson DR; Birt J; Noxon V; Varker H; Zimmerman N; Tkacz J
Curr Med Res Opin; 2022 Sep; 38(9):1641-1649. PubMed ID: 35866412
[TBL] [Abstract][Full Text] [Related]
10. Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015.
Hammond ER; Desta B; Near AM; Wang X; Jiang M
Lupus Sci Med; 2021 Sep; 8(1):. PubMed ID: 34556546
[TBL] [Abstract][Full Text] [Related]
11. Patterns and predictors of recurrent acute care use among Medicaid beneficiaries with systemic lupus erythematosus.
Feldman CH; Xu C; Williams J; Collins JE; Costenbader KH
Semin Arthritis Rheum; 2020 Dec; 50(6):1428-1436. PubMed ID: 32252975
[TBL] [Abstract][Full Text] [Related]
12. Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
Katz P; Nelson WW; Daly RP; Topf L; Connolly-Strong E; Reed ML
J Manag Care Spec Pharm; 2020 Mar; 26(3):275-283. PubMed ID: 32105178
[TBL] [Abstract][Full Text] [Related]
13. Healthcare utilization and costs of systemic lupus erythematosus in Medicaid.
Kan HJ; Song X; Johnson BH; Bechtel B; O'Sullivan D; Molta CT
Biomed Res Int; 2013; 2013():808391. PubMed ID: 23484162
[TBL] [Abstract][Full Text] [Related]
14. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Cho J; Shen L; Huq M; Kandane-Rathnayake R; Golder V; Louthrenoo W; Chen YH; Hamijoyo L; Luo SF; Wu YJ; Zamora L; Li Z; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake D; Chan M; Kikuchi J; Takeuchi T; Bae SC; Oon S; O'Neill S; Goldblatt F; Ng KPL; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Navarra SV; Lau CS; Hoi A; Morand EF; Nikpour M; Lateef A;
Lancet Rheumatol; 2023 Oct; 5(10):e584-e593. PubMed ID: 38251484
[TBL] [Abstract][Full Text] [Related]
15. Prescription Opioid Use in Patients With and Without Systemic Lupus Erythematosus - Michigan Lupus Epidemiology and Surveillance Program, 2014-2015.
Somers EC; Lee J; Hassett AL; Zick SM; Harlow SD; Helmick CG; Barbour KE; Gordon C; Brummett CM; Minhas D; Padda A; Wang L; McCune WJ; Marder W
MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(38):819-824. PubMed ID: 31557148
[TBL] [Abstract][Full Text] [Related]
16. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
[TBL] [Abstract][Full Text] [Related]
17. The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States.
Bell CF; Huang SP; Cyhaniuk A; Averell CM
Lupus; 2023 Feb; 32(2):301-309. PubMed ID: 36542670
[TBL] [Abstract][Full Text] [Related]
18. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.
Kariburyo F; Xie L; Sah J; Li N; Lofland JH
J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081
[No Abstract] [Full Text] [Related]
19. Predictors of flare in SLE patients fulfilling lupus low disease activity state: a cohort study of 292 patients with 36-month follow-up.
Cunha RN; Saraiva L; Jesus D; Doria A; da Silva JP; Inês LS
Rheumatology (Oxford); 2023 Nov; 62(11):3627-3635. PubMed ID: 36847423
[TBL] [Abstract][Full Text] [Related]
20. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
